OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer’s and Parkinson’s Diseases
Óscar Teijido, Ramón Cacabelos
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 3199-3199
Open Access | Times Cited: 57
Óscar Teijido, Ramón Cacabelos
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 3199-3199
Open Access | Times Cited: 57
Showing 26-50 of 57 citing articles:
Epigenetic enzymes: A role in aging and prospects for pharmacological targeting
E. G. Pasyukova, Alexander V. Symonenko, Olga Y. Rybina, et al.
Ageing Research Reviews (2021) Vol. 67, pp. 101312-101312
Closed Access | Times Cited: 19
E. G. Pasyukova, Alexander V. Symonenko, Olga Y. Rybina, et al.
Ageing Research Reviews (2021) Vol. 67, pp. 101312-101312
Closed Access | Times Cited: 19
Marine Natural Products from the Russian Pacific as Sources of Drugs for Neurodegenerative Diseases
Yu. S. Khotimchenko, Д. Н. Силачев, Vladimir L. Katanaev
Marine Drugs (2022) Vol. 20, Iss. 11, pp. 708-708
Open Access | Times Cited: 14
Yu. S. Khotimchenko, Д. Н. Силачев, Vladimir L. Katanaev
Marine Drugs (2022) Vol. 20, Iss. 11, pp. 708-708
Open Access | Times Cited: 14
Neuroprotection with Natural Antioxidants and Nutraceuticals in the Context of Brain Cell Degeneration: The Epigenetic Connection
Iván Carrera, Olaia Martínez, Ramón Cacabelos
Current Topics in Medicinal Chemistry (2019) Vol. 19, Iss. 32, pp. 2999-3011
Closed Access | Times Cited: 21
Iván Carrera, Olaia Martínez, Ramón Cacabelos
Current Topics in Medicinal Chemistry (2019) Vol. 19, Iss. 32, pp. 2999-3011
Closed Access | Times Cited: 21
A good marker does not mean a good target for clinical trials in Alzheimer's disease: the amyloid hypothesis questioned
Pedro J. Modrego, Antonio Lobo
Neurodegenerative Disease Management (2019) Vol. 9, Iss. 3, pp. 119-121
Open Access | Times Cited: 20
Pedro J. Modrego, Antonio Lobo
Neurodegenerative Disease Management (2019) Vol. 9, Iss. 3, pp. 119-121
Open Access | Times Cited: 20
Possible Epigenetic Role of Vitexin in Regulating Neuroinflammation in Alzheimer’s Disease
M. A. F. Yahaya, Siti Zaidathul Iman Zolkiffly, Mohamad Aris Mohd Moklas, et al.
Journal of Immunology Research (2020) Vol. 2020, pp. 1-7
Open Access | Times Cited: 17
M. A. F. Yahaya, Siti Zaidathul Iman Zolkiffly, Mohamad Aris Mohd Moklas, et al.
Journal of Immunology Research (2020) Vol. 2020, pp. 1-7
Open Access | Times Cited: 17
Gene Therapy for Alzheimer and Parkinson Diseases
Jasen F. Saad, Fawzy A. Saad
Current Gene Therapy (2023) Vol. 23, Iss. 3, pp. 163-169
Closed Access | Times Cited: 6
Jasen F. Saad, Fawzy A. Saad
Current Gene Therapy (2023) Vol. 23, Iss. 3, pp. 163-169
Closed Access | Times Cited: 6
Epigenetic Explorations of Neurological Disorders, the Identification Methods, and Therapeutic Avenues
Zeba Firdaus, Xiaogang Li
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11658-11658
Open Access | Times Cited: 2
Zeba Firdaus, Xiaogang Li
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11658-11658
Open Access | Times Cited: 2
Nutritional neurology: Unraveling cellular mechanisms of natural supplements in brain health
Suraj Kumar, Rishabha Malviya, Sonali Sundram
Human Nutrition & Metabolism (2023) Vol. 35, pp. 200232-200232
Open Access | Times Cited: 5
Suraj Kumar, Rishabha Malviya, Sonali Sundram
Human Nutrition & Metabolism (2023) Vol. 35, pp. 200232-200232
Open Access | Times Cited: 5
Human Periapical Cyst-Derived Stem Cells Can Be A Smart “Lab-on-A-Cell” to Investigate Neurodegenerative Diseases and the Related Alteration of the Exosomes’ Content
Marco Tatullo, Bruna Codispoti, Gianrico Spagnuolo, et al.
Brain Sciences (2019) Vol. 9, Iss. 12, pp. 358-358
Open Access | Times Cited: 15
Marco Tatullo, Bruna Codispoti, Gianrico Spagnuolo, et al.
Brain Sciences (2019) Vol. 9, Iss. 12, pp. 358-358
Open Access | Times Cited: 15
Epigenetic drugs as new emerging therapeutics: What is the scale's orientation of application and challenges?
Marzieh Ramezani Farani, Maryam Sarlak, Amir Gholami, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154688-154688
Closed Access | Times Cited: 5
Marzieh Ramezani Farani, Maryam Sarlak, Amir Gholami, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154688-154688
Closed Access | Times Cited: 5
In Vitro Assessment of the Genotoxic Hazard of Novel Hydroxamic Acid- and Benzamide-Type Histone Deacetylase Inhibitors (HDACi)
Annabelle Friedrich, Ann-Sophie Assmann, Lena Schumacher, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 13, pp. 4747-4747
Open Access | Times Cited: 11
Annabelle Friedrich, Ann-Sophie Assmann, Lena Schumacher, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 13, pp. 4747-4747
Open Access | Times Cited: 11
Epigenetic Studies in the Male APP/BIN1/COPS5 Triple-Transgenic Mouse Model of Alzheimer’s Disease
Olaia Martínez-Iglesias, Vinogran Naidoo, Iván Carrera, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2446-2446
Open Access | Times Cited: 7
Olaia Martínez-Iglesias, Vinogran Naidoo, Iván Carrera, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2446-2446
Open Access | Times Cited: 7
Histone Deacetylases as Epigenetic Targets for Treating Parkinson’s Disease
Yan Li, Zhicheng Gu, Shu-xian Lin, et al.
(2022)
Open Access | Times Cited: 7
Yan Li, Zhicheng Gu, Shu-xian Lin, et al.
(2022)
Open Access | Times Cited: 7
Activation of β2-adrenergic receptors prevents AD-type synaptotoxicity via epigenetic mechanisms
Ming Jin, Zhiyun Wei, Nagendran Ramalingam, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 11, pp. 4877-4888
Closed Access | Times Cited: 4
Ming Jin, Zhiyun Wei, Nagendran Ramalingam, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 11, pp. 4877-4888
Closed Access | Times Cited: 4
Histone post-translational modification and heterochromatin alterations in neurodegeneration: revealing novel disease pathways and potential therapeutics
Raven M. A. Fisher, Mariana P. Torrente
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 1
Raven M. A. Fisher, Mariana P. Torrente
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 1
Discovery of SDS-347 as a specific peptide competitive inhibitor of G9a with promising anti-cancer potential
Suraya Jan, Mohd Jamal Dar, Gauri Shankar, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2023) Vol. 1867, Iss. 9, pp. 130399-130399
Closed Access | Times Cited: 3
Suraya Jan, Mohd Jamal Dar, Gauri Shankar, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2023) Vol. 1867, Iss. 9, pp. 130399-130399
Closed Access | Times Cited: 3
Shifting the paradigm in treating multi-factorial diseases: polypharmacological co-inhibitors of HDAC6
Alexandria M. Chan, Steven Fletcher
RSC Medicinal Chemistry (2020) Vol. 12, Iss. 2, pp. 178-196
Open Access | Times Cited: 8
Alexandria M. Chan, Steven Fletcher
RSC Medicinal Chemistry (2020) Vol. 12, Iss. 2, pp. 178-196
Open Access | Times Cited: 8
Nutrigenomics in Parkinson’s disease: diversity of modulatory actions of polyphenols on epigenetic effects induced by toxins
Moara Rodrigues-Costa, Matheus Santos de Sousa Fernandes, Gabriela Carvalho Jurema Santos, et al.
Nutritional Neuroscience (2022) Vol. 26, Iss. 1, pp. 72-84
Closed Access | Times Cited: 4
Moara Rodrigues-Costa, Matheus Santos de Sousa Fernandes, Gabriela Carvalho Jurema Santos, et al.
Nutritional Neuroscience (2022) Vol. 26, Iss. 1, pp. 72-84
Closed Access | Times Cited: 4
Reversing memory/cognitive impairment with medicinal plants targeting inflammation and its crosstalk with other pathologies
Sheena E.B. Tyler, Luke D.K. Tyler
Brain Disorders (2023) Vol. 11, pp. 100094-100094
Open Access | Times Cited: 2
Sheena E.B. Tyler, Luke D.K. Tyler
Brain Disorders (2023) Vol. 11, pp. 100094-100094
Open Access | Times Cited: 2
Histone modifications in diseases
Mónica T. Fernandes, Hélder Almeida-Lousada, Pedro Castelo‐Branco
Elsevier eBooks (2020), pp. 1-15
Closed Access | Times Cited: 5
Mónica T. Fernandes, Hélder Almeida-Lousada, Pedro Castelo‐Branco
Elsevier eBooks (2020), pp. 1-15
Closed Access | Times Cited: 5
Epigenetic treatment of neurodegenerative disorders
Olaia Martínez-Iglesias, Ramón Cacabelos
Elsevier eBooks (2020), pp. 311-335
Closed Access | Times Cited: 3
Olaia Martínez-Iglesias, Ramón Cacabelos
Elsevier eBooks (2020), pp. 311-335
Closed Access | Times Cited: 3
Motor Coordination Disorders Evaluated through the Grid Test and Changes in the Nigral Nrf2 mRNA Expression in Rats with Pedunculopontine Lesion
Lisette Blanco-Lezcano, Esteban Alberti Amador, María Elena González Fraguela, et al.
Behavioral Sciences (2020) Vol. 10, Iss. 10, pp. 156-156
Open Access | Times Cited: 3
Lisette Blanco-Lezcano, Esteban Alberti Amador, María Elena González Fraguela, et al.
Behavioral Sciences (2020) Vol. 10, Iss. 10, pp. 156-156
Open Access | Times Cited: 3
Epigenetic Therapy for Alzheimer’s Disease
Sonam Fathima Mehak, Vikas Sahu, Apoorva Bettagere Shivakumar, et al.
(2023), pp. 199-217
Closed Access | Times Cited: 1
Sonam Fathima Mehak, Vikas Sahu, Apoorva Bettagere Shivakumar, et al.
(2023), pp. 199-217
Closed Access | Times Cited: 1
Epigenetics in Drug Discovery: Achievements and Challenges
Živa Korda, Philippos Koulousakis, Ehsan Pishva, et al.
(2024), pp. 145-165
Closed Access
Živa Korda, Philippos Koulousakis, Ehsan Pishva, et al.
(2024), pp. 145-165
Closed Access
